Nasdaq: Sensex, Nifty See Modest Gains On Solid US Data
From Nasdaq: Indian shares opened on a positive note with the S&P BSE Sensex and NSE Nifty index both edging
Category: Markets
Dow Jones & Company: Here are the risky options being linked to the sudden demise of Wednesday’s initial stock-market rally
From Dow Jones & Company: The article discusses a sudden and unexpected drop in the S&P 500 index, which occurred
Barchart: FCX Stock Forecast: Is Freeport-McMoRan a Good Cyclical Buy for 2024?
From Barchart: Despite a recent rebound, Freeport-McMoRan stock is not performing as well as the overall markets in 2023. The
Nasdaq: Nike (NKE) Q2 2024 Earnings Call Transcript
From Nasdaq: Nike Incorporated fiscal 2024 second-quarter conference call was led by Paul Trussell and included president and CEO, John
Dow Jones & Company: Dow Jones ends over 300 points higher as S&P 500 rebounds from biggest drop in 3 months
From Dow Jones & Company: U.S. stock markets rebounded on Thursday after a sharp selloff the previous day, with the
Barchart: 3 Dividend Stocks For High Total Returns
From Barchart: The article discusses the potential for dividend stocks to generate double-digit annualized returns in the future, using three
Nielsen Holdings PLC: Sensex, Nifty May See Modest Gains At Open
From Nielsen Holdings PLC: Indian shares may open with modest gains on Friday as new economic data from the U.S.
Dow Jones & Company: Pace of Japan’s consumer inflation slowed in November
From Dow Jones & Company: In November, Japan’s overall consumer prices rose 2.8% from a year earlier, a decrease from
StockStory: Why Are JFrog (FROG) Shares Soaring Today
From StockStory: JFrog’s shares rose 6.2% after an analyst upgraded the stock’s rating to Buy and raised the price target.
Nasdaq, Inc.: Australian Market Slightly Higher | Nasdaq
From Nasdaq, Inc.: The Australian stock market is trading slightly higher on Friday despite negative cues from global markets. The
Dow Jones & Company: Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
From Dow Jones & Company: The FDA has approved Wainua, developed by Ionis Pharmaceuticals and AstraZeneca, for the treatment of
Stockstory: Mission Produce (NASDAQ:AVO) Misses Q4 Sales Targets
From Stockstory: Mission Produce (NASDAQ:AVO) missed analysts’ revenue expectations in Q4 FY2023 with a 8.4% year on year increase to
NasdaqomaX.: Why Soleno Therapeutics Stock Ticked Higher on Thursday
From NasdaqomaX.: Soleno Therapeutics’ stock price received a 10% lift after a Guggenheim analyst raised the price target to $44
Dow Jones & Company: Elon Musk tells Cathie Wood he wants to make X a ‘giant brain’ and financial platform
From Dow Jones & Company: In a recent interview, Elon Musk discussed his plans to turn X into a “giant
Barchart: Has Crude Oil Put in an Early Seasonal Low?
From Barchart: The article discusses the cyclical nature of the crude oil market, with changes in consumer demand driven by
“Wall Street Journal”: For Warner-Paramount, Streaming Consolidation Is Easier Said Than Done
From “Wall Street Journal”: Warner Bros. Discovery considering merging with Paramount Global, but no formal talks have begun. This follows
Nasdaq: Why Canopy Growth Stock Dropped 13% This Week
From Nasdaq: Canopy Growth (NASDAQ:CGC) saw a 13% drop in its stock price this week following a reverse-stock split and
Dow Jones & Company: ‘The switch was flipped’: ETF flows pick up as stocks, bonds head for 2023 gains
From Dow Jones & Company: The article discusses how both stocks and bonds are heading for gains in 2023 after
Barchart: Stocks End Higher as Weak U.S. Economic News Bolsters Fed Rate-Cut Expectations
From Barchart: On Thursday, the S&P 500 Index, Dow Jones Industrials Index, and Nasdaq 100 Index all closed higher, with
Wall Street Journal: S&P 500 Rebounds After Worst Day Since September
From Wall Street Journal: The major stock market indexes have shown consistent gains over the past seven weeks, marking a
Nasdaq: Holiday Season Special | Nasdaq
From Nasdaq: This article discusses the seasonality of stock market returns and popular trading strategies based on seasonal trends. The
Dow Jones & Company: Nike eyes $2 billion in cost cuts in effort to ‘streamline’ amid softer outlook
From Dow Jones & Company: Nike Inc. plans to save $2 billion over the next three years to streamline the
Biodexa Announces Closing Of $6.0 Million Underwritten
From GlobeNewswire: Biodexa Pharmaceuticals PLC has announced the closing of a $6.0 million public offering, with the full exercise of
General Motors reaches deal with UAW, ending weeks-long strike
General Motors and the United Auto Workers union have reached a tentative contract agreement that could end a six-week-old strike
Stock market news live updates: Stock futures fall, Dow futures sink 300+ points after last week’s selloff – Yahoo Finance
Stock futures sank Sunday evening as investor jitters over rising coronavirus cases in key parts of the country stirred up